George Kwong

Company: Caribou Biosciences

Job title: Senior scientist

Seminars:

Exploring the Use of Genome Editing, Cell Armouring, & Other Approaches to Mitigate Immunogenicity 9:30 am

• Utilising CRISPR technologies to reduce immunogenicity of allogeneic CAR-T therapies • Combatting T-cell exhaustion to create a sustained and hyper-active antitumoural therapy • Assessing shielding technologies to protect allogeneic cells from immune surveillanceRead more

day: Day One